Abstract
This paper describes a detailed structure-activity relationship (SAR) analysis of the metabotropic glutamate receptor 4 (mGluR4) positive allosteric modulator, (-)-N-phenyl-7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxamide (PHCCC). We have now developed compounds with improved potency and efficacy; in addition, compounds are presented that show selectivity for mGluR4 versus the other mGluR subtypes.
Original language | English (US) |
---|---|
Pages (from-to) | 411-419 |
Number of pages | 9 |
Journal | ACS Chemical Neuroscience |
Volume | 1 |
Issue number | 6 |
DOIs | |
State | Published - Jun 16 2010 |
Externally published | Yes |
Keywords
- Allosteric modulation
- Metabotropic glutamate receptor 4
- PHCCC
- Parkinson's disease
- Positive allosteric modulator
- SAR
- Structure-activity relationship
ASJC Scopus subject areas
- Biochemistry
- Physiology
- Cognitive Neuroscience
- Cell Biology